好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Structured delirium care pathway is associated with reductions in length of stay, cost and readmissions in hospitalized adults
Aging, Dementia, and Behavioral Neurology
P4 - Poster Session 4 (5:30 PM-6:30 PM)
9-016
To determine if a delirium care pathway is associated with improved clinical outcomes in hospitalized adults.

Hospital-acquired delirium is associated with several negative consequences, such as prolonged hospitalization. Programs targeted at delirium prevention and treatment may affect these outcomes.  

In this retrospective cohort study, we compared outcomes before and after a delirium care pathway was implemented on a general medicine ward. The pathway included admission delirium risk assessment, delirium screening by nurses every twelve hours, and a targeted non-pharmacologic care bundle for high risk and delirious patients. We included all non-intensive care unit patients ≥50 years old hospitalized for at least 24 hours on the general medicine ward from 1/9/2016–1/8/2017 (pre-pathway) and 1/9/2017-1/8/2018 (post-pathway). Primary outcome was length of stay. Secondary outcomes included restraint use, safety attendant use, hospitalization cost, and 30-day readmission. Delirium screening was implemented with the care pathway, so delirium rates were only measured in the post-pathway period. Outcomes were compared between time periods using multivariable generalized linear, Poisson and logistic models as appropriate, adjusting for clinical variables that were significantly different between groups. 


5419 patients were included (2594 patients pre-pathway). Average age was 70±13 years; demographic variables remained constant over time. Delirium prevalence after pathway implementation was 24.3%. Mean length of stay decreased after the intervention by 0.8 days (95% CI 0.8, 1.1; p<0.0001). Hospitalization cost decreased on average by $850 per patient (95% CI -1505, -197; p<0.0001); odds of readmission were reduced by 30% (OR 0.7, 95% CI 0.6, 0.7; p<0.0001). Patient safety attendant (p=0.3) and restraint (p=0.2) use did not change. Delirium rate remained constant over the twelve months after pathway implementation (p=0.2).
Implementation of a delirium care pathway on a general medicine ward was associated with reductions in hospital length of stay, hospitalization cost and 30-day readmissions. 
Authors/Disclosures
Sara LaHue, MD
PRESENTER
The institution of Dr. LaHue has received research support from National Institute on Aging . The institution of Dr. LaHue has received research support from Larry L. Hillblom Foundation . The institution of Dr. LaHue has received research support from UCSF Claude D. Pepper Older Americans Independence Center . The institution of Dr. LaHue has received research support from UCSF Bakar Aging Research Institute. The institution of Dr. LaHue has received research support from Doris Duke Foundation . The institution of Dr. LaHue has received research support from National Institute on Aging . The institution of Dr. LaHue has received research support from Longevity Impetus Grants. Dr. LaHue has received publishing royalties from a publication relating to health care.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
S. A. Josephson, MD, FAAN (UCSF) Dr. Josephson has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Josephson has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for McGraw Hill---Harrison's Principles of Internal Medicine. Dr. Josephson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various legal firms. The institution of Dr. Josephson has received research support from NINDS. Dr. Josephson has received publishing royalties from a publication relating to health care. Dr. Josephson has received publishing royalties from a publication relating to health care.
No disclosure on file
No disclosure on file
No disclosure on file
Vanja C. Douglas, MD, FAAN (Univ of California, San Francisco) Dr. Douglas has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various legal firms. Dr. Douglas has received publishing royalties from a publication relating to health care. Dr. Douglas has received publishing royalties from a publication relating to health care.